Pharmaron Beijing Co., Ltd. logo

Pharmaron Beijing Co., Ltd. (300759)

Market Closed
10 Dec, 06:57
XSHE XSHE
¥
29. 37
+0.27
+0.93%
¥
51.78B Market Cap
- P/E Ratio
0.8% Div Yield
15,110,500 Volume
- Eps
¥ 29.1
Previous Close
Day Range
28.44 29.42
Year Range
20.47 37.63
Want to track 300759 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Pharmaron Beijing Co., Ltd. logo
300759 Pharmaron Beijing Co., Ltd.
29 Oct 2025
-
-
Pharmaron Beijing Co., Ltd. logo
300759 Pharmaron Beijing Co., Ltd.
28 Oct 2025
0.25
0.23
Pharmaron Beijing Co., Ltd. logo
300759 Pharmaron Beijing Co., Ltd.
27 Aug 2025
0.26
-
Pharmaron Beijing Co., Ltd. logo
300759 Pharmaron Beijing Co., Ltd.
27 Mar 2025
0.26
0.19
Pharmaron Beijing Co., Ltd. logo
300759 Pharmaron Beijing Co., Ltd.
25 Oct 2024
-
-
Pharmaron Beijing Co., Ltd. logo
300759 Pharmaron Beijing Co., Ltd.
23 Aug 2024
0.21
0.5
Pharmaron Beijing Co., Ltd. logo
300759 Pharmaron Beijing Co., Ltd.
20 Jun 2024
0.22
0.13
Pharmaron Beijing Co., Ltd. logo
300759 Pharmaron Beijing Co., Ltd.
25 Apr 2024
0.22
-
Pharmaron Beijing Co., Ltd. logo
300759 Pharmaron Beijing Co., Ltd.
28 Mar 2024
0.18
-
Pharmaron Beijing Co., Ltd. logo
300759 Pharmaron Beijing Co., Ltd.
27 Oct 2023
0.27
0.2

300759 Earnings Reports FAQ

What is the earnings per share (EPS) for 300759?

EPS data for 300759 is currently not available, as Pharmaron Beijing Co., Ltd has not reported recent earnings.

What is the company's earnings growth rate?

Over the past 2 years, the earnings growth rate has been approximately 7.24%, reflecting the 300759's performance and XSHE market conditions.

When is the next earnings release date?

Pharmaron Beijing Co., Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings were 0.23 per share, reported on 2025-10-28. For dividend history, visit the 300759 Dividends page.

What is the price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio is 127.70, calculated based on the most recent stock price of ¥29.37.